Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
886 Shares in United Therapeutics Corporation $UTHR Acquired by BAM Wealth Management LLC
03:37am, Monday, 06'th Apr 2026
BAM Wealth Management LLC purchased a new position in United Therapeutics Corporation (NASDAQ: UTHR) during the undefined quarter, according to the company in its most recent filing with the Securitie
Element Squared LLC Acquires New Position in United Therapeutics Corporation $UTHR
05:04am, Saturday, 04'th Apr 2026
Element Squared LLC bought a new position in shares of United Therapeutics Corporation (NASDAQ: UTHR) during the undefined quarter, according to its most recent 13F filing with the Securities and Exch
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Friday, 03'rd Apr 2026
United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CPRX or UTHR: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 03'rd Apr 2026
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Catalyst Pharmaceutical (CPRX) and United Therapeutics (UTHR). But which of these two stocks offers value
United Therapeutics (NASDAQ:UTHR) EVP Paul Mahon Sells 8,300 Shares of Stock
05:32am, Friday, 03'rd Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) EVP Paul Mahon sold 8,300 shares of the business's stock in a transaction on Thursday, April 2nd. The stock was sold at an average pric
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares of Stock
05:32am, Friday, 03'rd Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the stock in a transaction dated Wednesday, April 1st. The stock was sold at an average pric
United Therapeutics (NASDAQ:UTHR) CFO James Edgemond Sells 10,000 Shares
05:32am, Friday, 03'rd Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CFO James Edgemond sold 10,000 shares of United Therapeutics stock in a transaction dated Monday, March 30th. The stock was sold at an
Brookstone Capital Management Has $3.23 Million Holdings in United Therapeutics Corporation $UTHR
04:51am, Friday, 03'rd Apr 2026
Brookstone Capital Management grew its position in shares of United Therapeutics Corporation (NASDAQ: UTHR) by 25.4% in the undefined quarter, according to the company in its most recent 13F filing wi
United Therapeutics: Maintaining 'Strong Buy' On Second TETON Study Program Win
03:38pm, Wednesday, 01'st Apr 2026
United Therapeutics Corporation maintains a Strong Buy rating after a second phase 3 win for nebulized Tyvaso in idiopathic pulmonary fibrosis [IPF]. UTHR achieved superior FVC improvement in TETON-1
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Wednesday, 01'st Apr 2026
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Exchange Traded Concepts LLC Acquires 1,164 Shares of United Therapeutics Corporation $UTHR
04:05am, Wednesday, 01'st Apr 2026
Exchange Traded Concepts LLC lifted its holdings in shares of United Therapeutics Corporation (NASDAQ: UTHR) by 31.5% during the undefined quarter, according to the company in its most recent 13F fili
UTHR Stock Rises 12.5% on Promising Data From TETON-1 Tyvaso Study
01:06pm, Tuesday, 31'st Mar 2026
United Therapeutics jumps 12.5% as phase III TETON-1 data show strong lung function gains for Tyvaso in IPF, paving the way for a potential FDA filing.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Tuesday, 31'st Mar 2026
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo
09:13am, Tuesday, 31'st Mar 2026
United Therapeutics (NASDAQ:UTHR) surged more than 12% in pre-market trading on March 30 after positive TETON-1 trial data triggered price target raises from two major Wall Street firms.
United Therapeutics (UTHR) Moves 12.5% Higher: Will This Strength Last?
06:10am, Tuesday, 31'st Mar 2026
United Therapeutics (UTHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength
